450 studies found for:    "Lupus Erythematosus, Systemic"
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Rituximab;   Drug: Placebo;   Drug: Prednisone;   Drug: Acetaminophen;   Drug: Diphenhydramine
22 Terminated
Has Results
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Rituximab;   Drug: Methylprednisolone;   Drug: Acetaminophen;   Drug: Diphenhydramine
23 Completed
Has Results
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Placebo;   Drug: Belimumab 1 mg/kg;   Drug: Belimumab 4 mg/kg;   Drug: Belimumab 10 mg/kg
24 Not yet recruiting A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: ALX-0061;   Biological: Placebo
25 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
26 Recruiting Study of Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
27 Completed A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
Condition: Systemic Lupus Erythematosus
Intervention: Drug: A-623
28 Completed Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Other: Clinical and laboratory evaluations, transesophageal echocardiography, carotid duplex, transcranial duplex, and magnetic resonance of the brain
29 Completed PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: A-623;   Other: Placebo Comparator
30 Recruiting CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: blisibimod;   Drug: Placebo
31 Unknown  Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
Condition: Refractory Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic MSC (AlloMSC)
32 Not yet recruiting CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Blisibimod;   Drug: Placebo
33 Recruiting Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Patients Who Participated in ADDRESS II)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Atacicept 75 mg;   Drug: Atacicept 150 mg
34 Recruiting Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)
Condition: Systemic Lupus
Intervention: Drug: Arsenic trioxide
35 Suspended Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Condition: Systemic Lupus Erythematosus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
36 Unknown  Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Other: Preventive Cardiology;   Other: Usual Care
37 Completed Zostavax in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Zostavax vaccine
38 Terminated
Has Results
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Other: Placebo;   Biological: MEDI-570 0.03 MG;   Biological: MEDI-570 0.1 MG;   Biological: MEDI-570 0.3 MG;   Biological: MEDI-570 1 MG
39 Completed Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: cytarabine
40 Completed
Has Results
Vitamin D3 in Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus;   SLE;   Lupus
Interventions: Drug: Vitamin D3;   Drug: Vitamin D3 placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years